In renal collecting duct principal cells, arginine-vasopressin (AVP) controls water reabsorption by stimulating the insertion of the water channel aquaporin-2 (AQP2) into the plasma membrane. AVP binds to the G protein-coupled vasopressin type-2 receptor (V2R) stimulating adenylyl cyclase and thereby cAMP formation. Initiation of this signaling cascade leads to activation of protein kinase A (PKA). PKA phosphorylates AQP2 at serine 256 (S256), which is the key trigger for its redistribution from intracellular vesicles into the plasma membrane. The membrane insertion facilitates water reabsorption along an osmotic gradient and fine-tunes body water homeostasis.
Dysregulation of AVP-mediated water reabsorption, due to aberrations of AVP secretion or AVP-activated signaling causes or is associated with severe diseases. Decreased water reabsorption caused by mutations of V2R or AQP2 leads to nephrogenic diabetes insipidus, whereas an elevated blood plasma AVP level is associated with excessive water reabsorption in cardiovascular diseases such as chronic heart failure and the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
The significance of AVP-mediated water reabsorption stems not only from its implication in disease. The AVP-induced translocation of AQP2-bearing vesicles to and fusion with the plasma membrane represents a strictly cAMP-dependent exocytic process, which is currently not well understood. Other examples for a cAMP-dependent exocytosis are renin secretion in the kidney and H+ secretion in the stomach. Therefore, elucidation of molecular mechanisms governing the AQP2-translocation in renal principal cells not only helps to understand similar molecular processes in other cell types but may also pave the way to novel therapies for the treatment of diseases associated with disturbances of AVP-mediated water reabsorption.
Elucidating mechanisms controlling AQP2 requires collecting duct principal cell models. For this a number of different mammalian kidney cell lines are available. However, these models have several drawbacks. In many cell systems the protein level of AQP2 is low (Table 1; M1, HEK293, COS-7, MDCK, LLC-PK1)1-10, others ectopically overexpress human (MCD4, WT10)11,12 or rat (CD8)13 AQP2. In MCD4 and COS-7 cells the V2 receptor is not expressed. To our knowledge there is no permanent cell line as a model available, which is derived from the renal inner medullary collecting duct, that part of the kidney where AQP2 expression is most abundant, but from the cortical collecting duct1,11,13-16. Such cell models are for example the widely used immortalized mpkCCD (e.g.17) or the recently established mTERT-CCD14 cell lines. Both cell lines endogenously express AQP2 and V2R but since they are derived from the cortical collecting duct most likely contain a different proteome compared to inner medullary collecting duct (IMCD) cells. They must for example express different Na+ transport systems.
Here, we present a protocol to culture primary IMCD cells expressing V2R and AQP2 endogenously. This model, therefore, represents most closely the physiological situation in the renal collecting duct. As establishing the culture requires only standard laboratory equipment other laboratories can easily adopt this approach.